The goal of this clinical trial is to evaluate the effectiveness of the mHealth survivorship program in enhancing health-related quality of life among colorectal cancer survivors. It is hypothesized that participants receiving the mHealth-based survivorship program will report significantly higher levels of health-related quality of life and a lower level of distress, depression, anxiety, fatigue, and bowel dysfunction compared to those in the control group.
Participants in the intervention group will:
Use the survivorship programme through mHealth every day for 3 months Be called by the healthcare provider every 2 weeks for consultation
Participants in the control group will receive the usual care
be 18 or older (1);
Vietnamese-speaking CRC patients who have completed active treatment and are preparing for discharge (2);
provide consent and complete questionnaires independently (3);
no metastatic and second cancers (4);
mental health diseases;
receiving anxiety or depression treatment or cognitive/learning problems.
Parallel
Intervention Group
Other interventionParticipants in the intervention group will: Use the survivorship programme through mHealth every day for 3 months; Be called by the healthcare provider every 2 weeks for consultation
The Functional Assessment of Cancer Therapy-General (FACT-G)
Assesses health-related QoL, including physical function (consisting of 7 items), social and family relationships (7 items), emotional state (6 items), and functional abilities (7 items). Scores range from 0 to 100, with higher scores indicating better QoL. Cronbach's alpha of 0.89 for the scale, received the approval to use the FACT-G from the FACIT organisation
The distress thermometer screening tool (DT)
A self-report tool measuring distress on a scale from 0 (no distress) to 10 (extreme distress), focusing on a cutoff score of 4
The Depression Anxiety Stress Scales (DASS-21)
Consists of 21 items, with seven items for anxiety (DASS21-A), seven items for depression (DASS21-D) and seven items for stress (DASS21-S). It was validated for use in the Vietnamese population with good internal consistency (Cronbach's alpha: depression subscale-0.72; anxiety subscale-0.77; stress subscale-0.70, and overall scale-0.88).
The Functional Assessment of Cancer Therapy-Fatigue subscale (FACT-F)
with 13 items, likert scales from 0 (not at all) to 4 (ver much), which has been validated for use in the Vietnamese version with Cronbach's alpha coefficient α = 0.93
The Low anterior resection syndrome (LARS)
A 5-question questionnaire evaluated bowel functional symptoms. Scores were assigned to responses, determining the LARS score, which categorized results into "no LARS" (0-20), "minor LARS" (21-29), and "major LARS" (30-42). Cronbach's alpha was from 0.874 to 0.934
Click on the lead sponsor to view all of their trials.
This trial is not recruiting at the moment. You can still explore other options:
